DocHQ and Bodyline Medical Wellness Clinics have today announced a collaboration to produce a unique women’s health blood testing kit. The kit, which is designed to offer comprehensive insights into women’s hormonal health, will be co-branded DocHQ and Bodyline’s M Plan.
DocHQ will provide Bodyline Medical Wellness Clinics with access to its user-friendly patient platform for seamless patient registration, sample collection, testing and results service. The blood results will provide a benchmark for initial and ongoing clinical menopause treatment and support.
Madhur Srivastava, CEO of DocHQ, commented: “At DocHQ, we’re excited to work with Bodyline Medical Wellness Clinics, marking a significant stride in our commitment to scalable and innovative healthcare. This cooperation symbolises our shared vision to empower and support fast-growing health businesses, providing them with the tools and insights they need to thrive. Together, we’re crafting a future where every woman can access personalised and comprehensive healthcare solutions, facilitating informed decisions for enhanced wellbeing.”
Sally-Ann Turner, Founder and Managing Director of Bodyline Medical Wellness Clinics, said the collaboration will “increase patient accessibility to Bodyline’s M Plan personalised clinical menopause treatment and support plan.”
The blood test samples will undergo analysis at Alderley Lighthouse Labs, a UK registered laboratory. Here, a comprehensive assessment of hormones, vitamins and minerals will be conducted to provide accurate and reliable results.
Bernie Murphy, Head of Clinical Services at Bodyline Medical Wellness Clinics, explained: “The M Plan delivers life-changing results for women suffering with menopause symptoms and improves their quality of life. A woman’s menopause treatment and support is typically diagnosed on clinical grounds by understanding her personal symptoms, discussing her medical history, and undertaking hormonal blood tests, which are a means of checking and monitoring the presence and level of menopausal hormones in a woman’s blood. They provide the benchmark that can be beneficial to effectively treat, monitor and modify medical menopause treatments.”
DocHQ and Bodyline Medical Wellness Clinics have announced a new collaboration to produce a co-branded women’s health blood testing kit. The kit is designed to offer comprehensive insights into women’s hormonal health with a primary emphasis on menopause-related indicators, such as Follicle-Stimulating Hormone (FSH).
DocHQ will provide Bodyline Medical Wellness Clinics with access to its user-friendly patient platform for seamless patient registration, sample collection, testing and results service. The blood results will provide a benchmark for initial and ongoing clinical menopause treatment and support.
Madhur Srivastava, CEO of DocHQ, commented: “This cooperation symbolises our shared vision to empower and support fast-growing health businesses, providing them with the tools and insights they need to thrive. Together, we’re crafting a future where every woman can access personalised and comprehensive healthcare solutions, facilitating informed decisions for enhanced wellbeing.”
Sally-Ann Turner, Founder and Managing Director of Bodyline Medical Wellness Clinics, added: “Our collaboration with DocHQ increases patient accessibility to Bodyline’s M Plan personalised clinical menopause treatment and support plan.”
The home blood test samples will undergo analysis at Alderley Lighthouse Labs, a UK registered laboratory, with a comprehensive assessment of hormones, vitamins and minerals conducted to provide accurate and reliable results. Bernie Murphy, Head of Clinical Services at Bodyline Medical Wellness Clinics, said: “The M Plan delivers life-changing results for women suffering with menopause symptoms and improves their quality of life.”
DocHQ and Bodyline Medical Wellness Clinics have partnered to produce a co-branded women’s health blood testing kit. The kit is designed to offer comprehensive insights into women’s hormonal health, with a primary emphasis on menopause-related indicators.
DocHQ CEO Madhur Srivastava commented: “This cooperation symbolises our shared vision to empower and support fast-growing health businesses, providing them with the tools and insights they need to thrive. Together, we’re crafting a future where every woman can access personalised and comprehensive healthcare solutions, facilitating informed decisions for enhanced wellbeing.”
The home blood test samples will undergo analysis at Alderley Lighthouse Labs, a UK registered laboratory. The comprehensive assessment of hormones, vitamins and minerals will provide accurate and reliable results, which will be used to benchmark initial and ongoing clinical menopause treatment and support.
Bernie Murphy, Head of Clinical Services at Bodyline Medical Wellness Clinics, said: “The M Plan delivers life-changing results for women suffering with
Derick is an experienced reporter having held multiple senior roles for large publishers across Europe. Specialist subjects include small business and financial emerging markets.